The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: A single institutional survey

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)501
Number of pages1
JournalJournal of Thoracic Oncology
Volume1
Issue number5
DOIs
StatePublished - Jun 2006

Cite this